Skip to main content

Biomarin Pharmaceutical Inc 10-Q for FY2024 Q3

Biomarin Pharmaceutical Inc (BMRN)

10-Q 2024-10-31 For: 2024-09-30
View Original
Added on April 12, 2026

About this 10-Q

Biomarin Pharmaceutical Inc filed this 10-Q on October 31, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$745.74M
up 28.3% from $581.33M a year earlier
Net income
$106.08M
up 162.7% from net income of $40.38M a year earlier
Diluted EPS
$0.55
up 161.9% from $0.21 a year earlier